Efficacy and safety of 0.1% lodoxamide for the long-term treatment of superior limbic keratoconjunctivitis
Crossref DOI link: https://doi.org/10.1007/s10792-017-0588-1
Published Online: 2017-06-10
Published Print: 2018-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rodriguez-Garcia, Alejandro http://orcid.org/0000-0002-1419-2109
Macias-Rodriguez, Yolanda
Gonzalez-Gonzalez, Jose M.
Funding for this research was provided by:
FundaciĆ³n Santos y de la Garza-Evia, I.B.P.
License valid from 2017-06-10